Skip to main content
mybioMérieux.com
Our Specific Websites
Antimicrobial Resistance Website
bioMérieux Clinical Diagnostics
bioMérieux Industry
bioMérieux Recruitment
bioMérieux Corporate
bioMérieux Culture Media
en
fr
Search form
Search
Canada
Main menu
About us
Our Company
Social Responsibility
Environmental Commitment
bioMérieux Worldwide
Clinical Diagnostics
Solutions
Antimicrobial Resistance Management
C.difficile Infection Management
Emergency Department Patient Management
Lab Efficiency
Sepsis
Your Challenges
Healthcare Executive Challenges
Lab Challenges
Physician Challenges
Industrial Microbiology
Food
Biopharma
Cosmetics
Veterinary
News & Events
All news
Events
Resources
Customer service
Technical Library
Newsletter bioMérieux Innovation
Quality Certificates
Contact
Pioneering diagnostics
bioMérieux | Pioneering diagnostics
LATEST NEWS
24.03.2020
bioMérieux reçoit l’autorisation d’utilisation en urgence de la FDA pour le test BIOFIRE® COVID-19
24.03.2020
First-Quarter 2020 Business Review
24.03.2020
Information financière du 1er trimestre 2020
24.03.2020
bioMérieux receives Emergency Use Authorization for BIOFIRE® COVID-19 test
11.03.2020
bioMérieux met à disposition le premier de ses trois tests de diagnostic du coronavirus SARS-CoV-2
ALL NEWS
COVID-19 Update
COVID-19 Update
GLOBAL-PPS
L’enquête Global-PPS, une alliée dans la lutte contre la résistance aux antimicrobiens...
TEMPO®
Fully automated method for QI enumeration Health Canada approved!
Clinical solutions
Our solutions
Discover our solutions to current key problem areas
Products & Services
Learn more about bioMérieux’s Clinical Products & Services
Your Challenges
Did you know we address the issues of labs, physicians and healthcare executives?
Industrial solutions
Food
Solutions for Food safety & Food quality
Biopharma
Microbial Control Solutions for bioPharmaceutical Industries
Veterinary
Solutions for Veterinary Diagnostics
Cosmetics
Microbial Control Solutions for Cosmetics & Personal Care Industries
